Beacon Biosignals

United States - Boston, MA

• 14/11/2025
• Series B
• $86,000,000

Beacon's AI platform for brain data enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through FDA-cleared EEG wearables, novel machine learning algorithms, enormous datasets, and advances in software engineering, we are changing the way patients are treated for disorders of the brain.

Want to join the team? We’re hiring—check out the careers page on our website for more.

Please be advised that Beacon Biosignals does not ask for personal information outside of our official hiring process. If a role is not listed on our careers page, it is not an active job opening. We will never ask candidates to send money to supplement company equipment, and all official emails from our team will come from the @beacon.bio domain, never text messages or Teams messages.

Related People

Jacob Donoghue, MD PhDCo Founder

United States - Boston, Massachusetts

Beacon Biosignals: Beacon's AI platform for EEG enables and accelerates new treatments that transform the lives of patients with neurological and psychiatric disease. Through novel machine learning algorithms, enormous datasets, and advances in software engineering, we are changing the way patients are treated for disorders of the brain.

LinkedIn https://www.linkedin.com/in/jacob-donoghue-mdphd/